RSRoberto Saporetti

Roberto Saporetti

*This is an algorithmically generated author record based on publicly available information.

Roberto Saporetti has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Differential translocation of bacteriophages across the intestinal barrier in health and Crohn’s disease

    by Clara Douadi, Ilias Theodorou, Quentin Lamy-Besnier, Olivier Schiettekatte, Yanis Sbardella, Loïc Brot, Paolo Emidio Costantini, Roberto Saporetti, Alberto Danielli, Matteo Calvaresi, et al.

    SUMMARY: Impaired intestinal barrier function is a major feature of Crohn’s disease (CD), leading to exacerbated inflammation in response to the microbiota. In this context, the translocation of intestinal bacteriophages (phages) and their effects on the host have been little investigated. We used phage fluorescence imaging coupled with ex-vivo and in-vitro models that mimic physiological and inflammatory conditions and found that phages can translocate across the intestinal barrier without disrupting its integrity. Although the translocation rate across the intestinal epithelium depended on phage morphology and the condition of the barrier, these factors did not influence the crossing of phage across the vascular endothelium. Virome analysis confirmed that viral sequences shared between blood and stool samples are more abundant in CD patients than healthy subjects, indicating that a barrier defect facilitates phage translocation from the gut to the bloodstream.


  • Open Access

    Advanced photodynamic therapy with an engineered M13 phage targeting EGFR: Mitochondrial localization and autophagy induction in ovarian cancer cell lines

    by Barbara Bortot, Maura Apollonio, Gabriele Baj, Laura Andolfi, Luisa Zupin, Sergio Crovella, Matteo di Giosia, Andrea Cantelli, Roberto Saporetti, Luca Ulfo, et al.


  • Orthogonal nanoarchitectonics of M13 phage for receptor targeted anticancer photodynamic therapy

    by Luca Ulfo, Andrea Cantelli, Annapaola Petrosino, Paolo Emidio Costantini, Michela Nigro, Francesco Starinieri, Eleonora Turrini, Suleman Khan Zadran, Giampaolo Zuccheri, Roberto Saporetti, et al.

    Not all viruses are bad . We developed an orthogonal approach (genetic/chemical) to engineer M13 bacteriophages as targeted vectors for efficient photodynamic killing of cancer cells.


  • Open Access

    Spiky Gold Nanoparticles for the Photothermal Eradication of Colon Cancer Cells

    by Paolo Emidio Costantini, Matteo Di Giosia, Luca Ulfo, Annapaola Petrosino, Roberto Saporetti, Carmela Fimognari, Pier Paolo Pompa, Alberto Danielli, Eleonora Turrini, Luca Boselli, et al.

    Colorectal cancer (CRC) is a widespread and lethal disease. Relapses of the disease and metastasis are very common in instances of CRC, so adjuvant therapies have a crucial role in its treatment. Systemic toxic effects and the development of resistance during therapy limit the long-term efficacy of existing adjuvant therapeutic approaches. Consequently, the search for alternative strategies is necessary. Photothermal therapy (PTT) represents an innovative treatment for cancer with great potential. Here, we synthesize branched gold nanoparticles (BGNPs) as attractive agents for the photothermal eradication of colon cancer cells. By controlling the NP growth process, large absorption in the first NIR biological window was obtained. The FBS dispersed BGNPs are stable in physiological-like environments and show an extremely efficient light-to-heat conversion capability when irradiated with an 808-nm laser. Sequential cycles of heating and cooling do not affect the BGNP stability. The uptake of BGNPs in colon cancer cells was confirmed using flow cytometry and confocal microscopy, exploiting their intrinsic optical properties. In dark conditions, BGNPs are fully biocompatible and do not compromise cell viability, while an almost complete eradication of colon cancer cells was observed upon incubation with BGNPs and irradiation with an 808-nm laser source. The PTT treatment is characterized by an extremely rapid onset of action that leads to cell membrane rupture by induced hyperthermia, which is the trigger that promotes cancer cell death.